Drug Infusion Systems Market Report 2026
Global Outlook – By Product Type (Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System), By Route Of Administration (Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration), By Application (Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Drug Infusion Systems Market Overview
• Drug Infusion Systems market size has reached to $14.23 billion in 2025 • Expected to grow to $22.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Rising Healthcare Expenditure Drives Growth In The Drug Infusion Systems Market • Market Trend: Advancements in Infusion Therapy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Drug Infusion Systems Market?
Drug infusion systems are medical devices that are used to deliver medications and fluids into a patient's body through a catheter or needle. Drug infusion systems are commonly used in hospitals, clinics, and other healthcare settings to administer medications, such as pain relief drugs, antibiotics, chemotherapy drugs, and fluids, to patients. The main types of drug infusion systems are elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. An elastomeric infusion system is a flexible container that delivers medication at a constant rate for short-term infusion therapy and is used for short-term drug infusion therapy in hospitals, clinics, and home care settings. They are administered intravenously, subcutaneously, arterially, epidurally, and in other modes of administration for various applications such as oncology and chemotherapy; diabetes; analgesia; nutrition; hematology; pediatrics; and other applications by end users including hospitals, ambulatory surgical centers, diagnostic centers, and other end users.
What Is The Drug Infusion Systems Market Size and Share 2026?
The drug infusion systems market size has grown strongly in recent years. It will grow from $14.23 billion in 2025 to $15.51 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing hospitalization rates, rising prevalence of chronic diseases, expansion of oncology and chemotherapy treatments, growing use of intravenous drug delivery, improved availability of infusion technologies.What Is The Drug Infusion Systems Market Growth Forecast?
The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $22.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing adoption of connected infusion systems, rising demand for ambulatory and homecare infusion solutions, expansion of precision drug delivery approaches, growing focus on workflow automation in hospitals, increasing investments in smart healthcare infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising integration of dose error reduction systems, growing use of multi-channel infusion devices, expansion of home-based infusion therapies, enhanced focus on patient safety features.
Global Drug Infusion Systems Market Segmentation
1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System 2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration 3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications 4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users Subsegments: 1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps 2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components 3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps 4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps 5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies 6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps 7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps 8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For ChemotherapyWhat Is The Driver Of The Drug Infusion Systems Market?
The growing healthcare expenditure is expected to propel the growth of the drug infusion systems market going forward. Healthcare expenditure refers to the total amount spent on healthcare goods and services in a given period, typically a year. As healthcare expenditures increase, hospitals, clinics, and other healthcare institutions have more resources to invest in advanced drug infusion systems, leading to a higher demand for these devices. For instance, in May 2024, according to reports published by the Office for National Statistics (ONS), a UK-based national statistical institute, total healthcare spending rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Therefore, the growing healthcare expenditure would drive the growth of the drug infusion systems industry.Key Players In The Global Drug Infusion Systems Market
Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Drug Infusion Systems Market Trends and Insights
Major companies involved in the drug infusion systems market are developing advanced technology, such as cloud-based infusion management systems, to enhance patient care, improve accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that facilitate the monitoring, administration, and tracking of medication infusions via the cloud. For instance, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system designed to meet the unique needs of home and specialty infusions. Eitan Insights is designed to provide healthcare professionals with real-time data and analytics, enabling them to monitor patients remotely and adjust treatment plans as needed. This system enhances medication safety by reducing the risk of errors and improving adherence to prescribed protocols.What Are Latest Mergers And Acquisitions In The Drug Infusion Systems Market?
In November 2025, Biogen Inc., a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. With this acquisition, Biogen aims to strengthen its drug‑delivery capabilities by integrating Alcyone’s ThecaFlex DRx implantable intrathecal system, thereby enhancing patient experience and broadening access to its CNS therapies. Alcyone Therapeutics Inc is a US-based Company that provide drug infusion systems
Regional Outlook
North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainNeed data for a specific geography? Request Regional Data
What Defines the Drug Infusion Systems Market?
The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Drug Infusion Systems Market Report 2026?
The drug infusion systems market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Drug Infusion Systems Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $15.51 billion |
| Revenue Forecast In 2030 | $22.23 billion |
| Growth Rate | CAGR of 9.4% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Route Of Administration, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |